FDA Approved.
FDA Approved.
A visionary company
Transforming ophthalmic care with sustained release therapies
Hydrogel Technology
A platform Engineered for Ocular Innovation
Driven by a vision
Pioneering a new era of drug delivery in ophthalmology
Ocular Therapeutix is a biopharmaceutical platform company leveraging its formulation expertise to develop transformational drug treatments that enhance people’s lives.
Featured Press Release
Effective Oct. 1, 2019, permanent and specific J-code (J1096) for DEXTENZA